What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der ...

Follow-up results from the phase 3 EMBER-3 study showed that, as a monotherapy, Inluriyo demonstrated a 38% reduction in the ...

Galderma’s Nemluvio (nemolizumab) has shown rapid relief of itch, as well as improvement in sleep, in patients with atopic ...

When influence outpaces expertise However, the rise of health content on social media has also fuelled the parallel problem ...

The industry is now entering the next era by embedding AI directly into the software field teams’ use every day. The step ...

Health equity is an ambitious goal, but the drive to deliver life-changing innovation to all eligible patients is ...

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional ...

Nektar Therapeutics has announced top-line results from its trial of rezpegaldesleukin to treat severe to very severe ...

AstraZeneca and Daiichi Sankyo’s Enhertu, in combination with pertuzumab, has been approved by the US FDA to treat adult ...

Creative agency Havas Life London has launched an impactful new campaign, ‘The World’s Rarest Disease’, highlighting the ...

Building a trusted data foundation The starting line for any successful AI journey is data readiness and quality. Before ...

The 2025 edition of PMLiVE’s T40 list of creative agencies working on advertising, branding, creative and design projects in ...